Less-frequent mandated earnings could be a positive, but the large pool of private capital may keep unicorns from coming to market.

Beijing Tong Ren Tang Healthcare Investment, a subsidiary of major Hong Kong-listed traditional Chinese medicine group Tong Ren Tang, plans to raise up to HK$897.7 million by offering 108.2 million ...

Bankers have said the move could have a significant impact on ⁠Hong Kong's rich IPO pipeline, at least in the short-term ...

Hong Kong's bourse operator has proposed new measures to bolster initial public offerings, a move that is expected to further ...

Generate Biomedicines IPO highlights AI-driven drug discovery, strong backing, promising pipeline, and investor confidence signals.

Malaysia's Sunway Healthcare Holdings surged 28% on its market debut ​on Wednesday, after raising 2.86 billion ringgit ($732 million) in the country's biggest initial public offering in almost a ...

BioVie is eyeing a $19.7 million IPO for a spinout focused on bringing a new formulation of an approved kidney failure drug to market as a potential treatment for liver disease. | BioVie is eyeing a ...

SpyGlass Pharma Inc., which is promising an intraocular lens that will reshape the treatment of glaucoma, emerged from its initial public offering last month with a big boost from Wall Street.

Gov. Maura Healey is using a new executive order to procure more energy supply and storage in Massachusetts, an effort her ...

More than 10 pre-profit drug developers are seeking Hong Kong listings as AI-powered biotech platforms draw growing investor interest More than 10 loss-making biotechnology companies have filed for ...